ISHLT - ISHLT 2023 43rd Annual Meeting & Scientific Sessions
How would you like your name to appear on your certificate?
Profession
Select Your Profession
Nurse
Pharmacist
Physician
Other
Transplant Coordinator
Next
What activities did you attend at the event?
Wednesday, April 19 - 8-9:30 am
-- Select an Activity --
PLENARY 1 - Opening General Session
Wednesday, April 19 - 10-11 am
-- Select an Activity --
SESSION 01 - A Bridge Too Far? Ethics of Organ Procurement using Thoracic Normothermic Regional Perfusion
SESSION 02 - Diving Into the Role of Mitochondria in Heart Transplantation
SESSION 03 - Back to the Future of AMR: A Multidisciplinary Symposium
SESSION 04 - Pulmonary Arterial Hypertension is Risky Business!
SESSION 05 - Shots! Shots! Shots! COVID-19 Vaccines in Heart Transplant Recipients
SESSION 06 - Pediatric M.C.S. = Multi-center Collaborative Success!
SESSION 07 - There and Back Again: Science of Lung Ischemia-Reperfusion Injury and Primary Graft Dysfunction
Wednesday, April 19 - 1-2 pm
-- Select an Activity --
SESSION 08 - JHLT Year in Review
SESSION 09 - Diagnosis of Heart Transplant Rejection: Out With the Old, In With the New
SESSION 10 - Multidisciplinary Avengers: Defeating The Lung Primary Graft Dysfunction Hydra (Debates)
SESSION 11 - A Mile High in Denver: Elevating Our Understanding and Management of Pediatric and Adult MCS Infections
SESSION 12 - Four to Go: WHO Group 4/CTEPH
SESSION 13 - Rings of Power: Cardiopulmonary Effects of EVLP
SESSION 14 - MUCH ADO ABOUT NOTHING? Using Artificial Intelligence for the Best Heart Transplantation Outcomes
Wednesday, April 19 - 2:15-3:45 pm
-- Select an Activity --
SESSION 15 - La Vida Loca: Expanding the Heart Donor Pool with DCD – Pearls and Pitfalls (Debates
SESSION 16 - If at First You Don't Succeed, Try, Try Again! Heart Failure and Transplantation in Fontan Patients
SESSION 17 - Donor Lung Allocation: Prioritizing Urgency, Access or Outcomes - What Matters Most?
SESSION 18 - Chronic Thromboembolic Pulmonary Hypertension: A Decade of Progress
SESSION 19 - A Short Bridge to Heart Transplantation: Are We Building It Right?
SESSION 20 - CLAD the Inhaler: Novel Biomarkers of CLAD Pathogenesis
SESSION 21 - Cardiac Allograft Vasculopathy: From Bench to Bedside
Wednesday, April 19 - 4:15-5:15 pm
-- Select an Activity --
SESSION 22 - Pregnancy and Beyond: Reproductive Health in Heart and Lung Failure
SESSION 23 - Different Continents, Same Problems: Global Perspective on Cardiogenic Shock
SESSION 24 - Top Lung: I Feel the Need for Speed -- to Get You Eating and Drinking
SESSION 25 - Transplants and Pulmonary Hypertension
SESSION 26 - Organ Allocation Strategy: Algorithms to Implement Equity
SESSION 27 - New Tools for the Kids: Diagnosis of Heart Transplant Rejection and Registries for Heart Function in Pediatrics
SESSION 28 - The Fifth Element: Genetic Engineering in Lung Transplantation
Wednesday, April 19 - 5:30-6:30 pm
-- Select an Activity --
MINI ORAL 01 - Scanning the (Rocky Mountain) Horizon: Biomarker Discovery and Understanding Outcomes in Heart Transplantation
MINI ORAL 02 - THE FORCE AWAKENS: Advances in Lung Preservation to Improve Donor Selection and Recipient Outcomes
MINI ORAL 03 - Bugs, Drugs, and Thugs: Fighting Infection in VADs Any Way We Can
MINI ORAL 04 - Outcomes, Predictions, and Monitoring, Oh My! In the Wonderful World of Heart Transplant
MINI ORAL 05 - After the Dust Settles: Long-term MCS Outcomes
MINI ORAL 06 - THE EMPIRE STRIKES BACK: Progress in Chronic Lung Allograft Dysfunction (CLAD)
Thursday, April 20 - 8-9:30 am
-- Select an Activity --
PLENARY 2 - General Session II
Thursday, April 20 - 10-11 am
-- Select an Activity --
SESSION 29 - The Right MCS Devices for the Right Patients
SESSION 30 - Exploring the Limits in Heart Transplantation in Children and Adults
SESSION 31 - Winter Soldier: Merging Basic and Clinical Science to Overcome Perioperative Challenges (debates)
SESSION 32 - Medical Management of PH: Something Old, Something New, Something Borrowed, Something Blue
SESSION 33 - THE TEMPEST: Infections in Heart Transplant Donors and Recipients
SESSION 34 - Balancing the Scales: Healthcare Disparities in Heart Transplantation
SESSION 35 - An Unexpected Journey: Perfusion Science in Lung Transplantation
Thursday, April 20 - 1-2:30 pm
-- Select an Activity --
SESSION 36 - The Achilles Heel: Frailty in Heart Transplant and LVAD Candidates
SESSION 37 - I Spy With My Little Eye: Multimodal Imaging in Durable Mechanical Circulatory Support
SESSION 38 - The Unusual Suspects: Immune and Tissue Drivers of Lung Allograft Pathologies
SESSION 39 - Righting a Wronged Ventricle
SESSION 40 - Early Career Clinical Case Dilemmas: The Best of the Best Award Session
SESSION 41 - As Good as It Gets: Patient Centered Outcomes in Lung Transplant
SESSION 42 - Current Challenges in Pediatric Heart Transplant Selection and Outcomes
Thursday, April 20 - 3-4 pm
-- Select an Activity --
SESSION 43 - Would You Rather: Choices at the End of the Shock Road
SESSION 44 - Mountain for Every Miracle! Field of Cardio-Oncology: The High-Yield Tips (Debates)
SESSION 45 - PTLD After Thoracic Organ Transplantation: New Considerations and Novel Therapies
SESSION 46 - Suspicious Minds: Immunizations in the Pre- and Post-Transplant Period
SESSION 47 - Predicting the Future: Impact of Various Factors on Outcomes After Heart Transplantation
SESSION 48 - Sex, Race and Social Determinants of Health in MCS Care
SESSION 49 - Days of Our Lives: Lung Donor-Recipient Allocation and Outcomes
Thursday, April 20 - 4:15-5:15 pm
-- Select an Activity --
MINI ORAL 07 - Waste Not Want Not: Pushing the Boundaries in Donor Heart Selection!
MINI ORAL 08 - A NEW HOPE: Lung Transplant Candidate Selection
MINI ORAL 09 - A Quick Trip Through the Pediatric Heart Function and Transplant Journey
MINI ORAL 10 - Mechanical Circulatory Support: We Like To Move It, Move It!
MINI ORAL 11 - ATTACK OF THE CLONES: Infectious Threats after Lung Transplant
MINI ORAL 12 - A New Frontier: Emerging Approaches for Diagnosis and Immune Modulation in Heart Transplantation
Friday, April 21 - 8-9 am
-- Select an Activity --
SESSION 50 - Assessment of COVID-19 Positive Donor for Heart Transplant
SESSION 51 - High Yield Tips for LVAD or Heart Transplant in Cause-Specific Cardiomyopathies
SESSION 52 - Immune Checkpoints in Thoracic Transplantation: Lessons Learned from Cancer
SESSION 53 - It Takes a Village: The Multi-Disciplinary Approach to Durable LVAD Candidacy
SESSION 54 - Hiding in Plain Sight: Science of Lung Antibody-Mediated Rejection
SESSION 55 - THE TAMING OF THE SHREW: All About Antibodies: Desensitization, AMR, and More in Heart Transplant
SESSION 56 - The Curious Case of CLAD Phenotypes
Friday, April 21 - 9:30-11 am
-- Select an Activity --
SESSION 57 - Novel Desensitization Approaches to Facilitate Transplantation for Highly Sensitized Candidates
SESSION 58 - For All Ages: MCS Support in Congenital Heart Disease in Children and Adults
SESSION 59 - Die Hard: Preventing and Managing Hard-to-Treat Fungal and Bacterial Infections in the Perioperative Setting
SESSION 60 - What's New with the ESC/ERS Guidelines 2022 for Pulmonary Hypertension
SESSION 61 - Philip K. Caves Award Candidate Presentations
SESSION 62 - Deus Ex Machina: Transformation of Heart Transplantation by Machine Perfusion
SESSION 63 - How Long is My Bridge? ECMO and Durable VAD Outcomes
Friday, April 21 - 1-2 pm
-- Select an Activity --
SESSION 64 - At the Limits of Care: Sailing the Rough Seas with Awake Patients on Pumps
SESSION 65 - Cardiac Allograft Vasculopathy – What Does the Future Hold?
SESSION 66 - Catch Me If You Can: Successful Patient Transitions from Pediatric into Adult Thoracic Transplant Programs - A Center-Based Approach
SESSION 67 - Challenges of PH Management in Special Populations
SESSION 68 - How It Started...How It's Going: Omics and AI in Heart Transplant Biopsies and Rejection Surveillance
SESSION 69 - MCS: Bleeding and Clotting - We Just Can't Win!
SESSION 70 - Lost in Translation: Molecular Tools in Lung Transplantation
Friday, April 21 - 3:45-4:45 pm
-- Select an Activity --
SESSION 78 - Acute Mechanical Circulatory Support: Guidelines, Consensus and Practical Issues
SESSION 79 - Unravelling Deaths in Heart Transplantation: Turning Tragedy into Triumph
SESSION 80 - Rocky Mountain High: Scaling New Heights in CMV
SESSION 81 - Novel Imaging Modalities: Tools to Assess Long Term Prognosis After Heart Transplant
SESSION 82 - More Than A Number: Navigating the Complexities of Psychosocial Support in Heart Transplantation
SESSION 83 - What's Drugs Got To Do With It: Medication Highlights in Heart Transplantation
SESSION 84 - One for the Money: WHO Group 1/Pulmonary Arterial Hypertension
Friday, April 20 - 2:15-3:15 pm
-- Select an Activity --
SESSION 71 - Around the World in 60 Minutes: Approaches to Infected Donors - Heart and Lung Transplant Considerations
SESSION 72 - Now Is Not the Time to Relax: Vasoplegia after Heart Transplant
SESSION 73 - Rejecting the Old Ways: The Future of CLAD Monitoring From Infancy to Adulthood
SESSION 74 - Connecting the Clots: Journey of an Acute to Chronic Pulmonary Embolism
SESSION 75 - THE COMEDY OF ERRORS: New Allocation Policy, DCD Donors...What About Primary Graft Dysfunction?
SESSION 76 - Spotlight on Nursing and Allied Health MCS Intervention Science
SESSION 77 - New Frontiers in Biomarker Development: Antibodies, Omics, and Graft Injury
Friday, April 21 - 5-6 pm
-- Select an Activity --
MINI ORAL 13 - Analyzing the Present and Improving the Future in Heart Transplantation
MINI ORAL 14 - THE PHANTOM MENACE: Basic Science Mechanisms of Chronic Lung Allograft Dysfunction (CLAD)
MINI ORAL 15 - The Full Spectrum of Innovation in MCS
MINI ORAL 16 - THE WINTER'S TALE: Hypothermic Machine Preservation of Donor Hearts
MINI ORAL 17 - THE CLONE WARS: OR and Peri-operative Improvements in Lung Transplantation
MINI ORAL 18 - The COVID-19 Beat: COVID-19 and Heart Transplantation
Saturday, April 22 - 8-9 am
-- Select an Activity --
SESSION 85 - AS YOU LIKE IT: Predictors of Post Transplant Mortality Between Donor and Recipient Factors
SESSION 86 - Medicine is a Science of Uncertainty and an Art of Probability: Patient Selection for Heart Transplantation
SESSION 87 - Durable MCS: Staying Alive!
SESSION 88 - Contagion Meets Outbreak: Lessons Learned from COVID-19 in Lung Transplantation
SESSION 89 - Medications and Machines: Which Ones Improve Pediatric Heart Transplant Outcomes?
SESSION 90 - ALL'S WELL THAT ENDS WELL: The Three P's to Transplant Success: Protection, Preservation, and (em)Powering the Donor Heart
Saturday, April 22 - 9:30-11 am
-- Select an Activity --
PLENARY 3 - General Session III
Saturday, April 22 - 11:15-12:15 pm
-- Select an Activity --
SESSION 91 - Multi-Organ Transplant Outcomes: When are Two Organs Better Than One in Heart Transplantation?
SESSION 92 - A Fungus Among Us: Advances in Fungal Biology
SESSION 93 - A MIDSUMMER NIGHT'S DREAM: From Mitochondria to Xenotransplantation: Novel Research Coming to You!
SESSION 94 - Friday Night Lights: Lung Transplantation Peri-operative Medicine
SESSION 95 - Bad Medicine on the Edge of a Broken Heart: Adverse Events in MCS
SESSION 96 - Unbreak My Heart: Recovery and Weaning in MCS Patients
Saturday, April 22 - 12:30-1:30 pm
-- Select an Activity --
SESSION 97 - MEASURE FOR MEASURE: Rejection Surveillance: All That Glitters is Not Gold
SESSION 98 - Andromeda Strain: Human-Viral Interactions in Lung Transplantation
SESSION 99 - ECMO is a Four-Letter Word: Strategies and Destinations For Patients on Support
SESSION 100 - Cutting to the Heart of the Matter: From Procurement to Implant
SESSION 101 - Brave New World: Improving EVLP Science
SESSION 102 - Love, Actually: Rejection in Lung Transplantation
Previous
Next
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
I agree
Previous
Next
Overall how valuable was the educational content of the 43rd Annual Meeting & Scientific Sessions to you?
Very Valuable
Valuable
Neutral
Somewhat Valuable
Not At All Valuable
Previous
Next
Was the educational content scientifically sound?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Did you attend the session in its entirety?
Yes
No
Previous
Next
If no, please explain:
Previous
Next
Did you perceive any commercial bias or influence in the educational content?
Yes
No
Previous
Next
If yes, please explain:
Previous
Next
Did this program improve your Skill or Strategy in your role or contribution as a member of the healthcare team?
Yes
No
Previous
Next
If no, why not?
Previous
Next
Do you believe your participation in this activity will positively impact your healthcare team?
Yes
No
Previous
Next
If yes, how?
Previous
Next
If no, why not?
Previous
Next
What questions are you having in your practice that you would like to see addressed in an educational activity?
Previous
Next
PHARMACISTS: If you do not provide your NABP ID AND your DATE OF BIRTH, your hours will not be uploaded to CPE Monitor.
(CPE Monitor) NABP e-Profile ID (ePID) - Example 123456:
(CPE Monitor) Date of Birth (MM/DD) - Example September 24 would be 0924:
Previous
